Outcomes and Readmissions After Continuous Flow Left Ventricular Assist Device: Heartmate II Versus Heartware Ventricular Assist Device

Tuncer O. N., KEMALOĞLU C., ERBASAN O., GÖLBAŞI İ., TÜRKAY C., BAYEZİD Ö.

TRANSPLANTATION PROCEEDINGS, cilt.48, sa.6, ss.2157-2161, 2016 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 48 Sayı: 6
  • Basım Tarihi: 2016
  • Doi Numarası: 10.1016/j.transproceed.2016.03.056
  • Dergi Adı: TRANSPLANTATION PROCEEDINGS
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.2157-2161
  • Akdeniz Üniversitesi Adresli: Evet

Özet

Introduction. Donor organ shortage is still a problem for heart transplantation. Only 10% of patients in waiting list undergo heart transplantation. Over the last 5 years, 2 different continuous flow pumps, the HeartMate II and the HeartWare, have been successful clinically in the alternative treatment of patients with end-stage heart disease.